Can We Predict Muscle Weakness Occurring Due To Aging?

A new largescale genetic analysis has discovered the biological mechanisms that contribute to making people more susceptible to muscle weakness later in life. It was found that diseases like osteoarthritis and diabetes may play a large role in susceptibility.

The study is published in the journal Nature Communications.

Sarcopenia Increases Diabetes Risk
In older adults, sarcopenia or age-related muscle loss was found to be a contributing factor to diabetes, stated new research.

‘Biological mechanisms and biomarkers that make a person more susceptible to muscle weakness later in life discovered. People with muscle weakness share common genetic pathways with metabolic diseases such as type-2 diabetes, and autoimmune disease like osteoarthritis, and rheumatoid arthritis.’
Read More..

Tweet it Now

Sarcopenia which is a type of muscle loss leading to severe weakness occurs with aging. This can impact the patient’s everyday life. Sarcopenia is experienced by 10 per cent of people over 50. This disease is linked to higher death rates. Many causes can impact likelihood of developing this weakness.

In a genetic analysis of over 250,000 people aged over 60, the team led by researchers at the University of Exeter looked at handgrip strength, using thresholds of muscle function loss derived from international definitions of sarcopenia.

The team then conducted genetic analysis and found that specific biological mechanisms push some people towards sarcopenia, whilst protecting others. The study identified 15 areas of the genome, or loci, associated with muscle weakness, which also included 12 loci not implicated in previous analyses of continuous measures of grip strength.

Sarcopenia - Causes, Symptoms, Diagnosis, Complications, Treatment & Prevention
Sarcopenia is the loss of skeletal muscle mass, strength and function associated with the aging process.

Other causes of sarcopenia include biomarkers in blood like red blood cells and inflammation. Together, these results highlight specific areas for identifying those at most risk or for intervention.

Lead author Garan Jones said, "The strongest associations we found were close to regions of the genome regulating the immune system, and growth and development of the musclo-skeletal system. However we also discovered associations with regions not previously known to be linked to musclo-skeletal traits.”

Hormone Therapy Minimizes Sarcopenia Linked to Aging
In postmenopausal women, the prolonged use (defined as ≥13 mo) of hormone therapy (HT) was linked to higher muscle mass and less chance of sarcopenia, stated new study.

On analysis, the researchers found that in older people muscle weakness shared common genetic pathways with metabolic diseases such as type-2 diabetes, and auto-immune conditions such as osteoarthritis and rheumatoid arthritis. In people with an increased risk of these conditions, sarcopenia may be a key outcome to look out for and prevent.

Garan Jones added, “We hope that by understanding the genetic contributions to muscle weakness with age, we will be able to highlight possible therapeutic interventions earlier in life, which would lead to a happier and healthier old age."

Epidemiologic Aspects of the Three Distinct Physiological Components of Sarcopenia
Progressive and generalised loss of muscle mass and strength is characterized by Sarcopenia an age-related syndrome.

Source-Medindia